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Summary: A radioimmunoassay for extracted, N-acetylated human serum serotonin (5-hydroxytryptamine)
is described. Antisera were raised in rabbits against a conjugate of bovine serum albumin with serotonin
hemisuccinamide. Polyethylene glycol in combination with anti-rabbit immunoglobulins was used to separate
bound and unbound ns\-Bolton Hunter-strolonin conjugate. Ethanol precipitation of serum proteins was
used to extract serotonin, which was subsequently acetylated with acetic anhydride to N-acetyl serotonin.
The average recovery was 66%. The minimal detectable concentration of N-acetyl serotonin was 0.012 μηιοΐ/ΐ
serum (25 fmol per tube). The intra-assay precision (CV) was 6.8% (n = 20) at a level of 0.9 ± 0.06 μιηοΐ/ΐ.
The inter-assay CV was 10% at a level of 0.49 ± 0.049 μπιοΐ/ΐ, and 25% (n = 10) at a level of 2.16 ± 0.53.
Analytical recovery of serotonin, corrected for losses during extraction and acetylation, was 99 ± 13%. The
only substance cross-reacting with the antibody was endogenous N-acetyl serotonin. This was detectable
when the acetylation Step was omitted, and it can be removed by extraction before the acetylation. The
observed r nge for the concentration of serotonin in serum was for 59 women 0.45 — 3.46 (mean + SD:
1.37 ± 0.63 μπιοΐ/ΐ) aiid for 59 men 0.19 - 2.8 (mean ± SD: 1.18 ± 0.56 μιηοΐ/ΐ). All values are corrected
for endogenous N-acetyl serotonin: observed r nge 0 — 0.18 (mean ± SD: 0.03 ± 0.03 μηιοΐ/ΐ).
Radioimmunologische Bestimmung des Serotonins in Humanserum
Zusammenfassung: Wir beschreiben die radioimmunologische Bestimmung des extrahierten und N-acetylier-
ten Serotoni s (5-Hydroxytryptamin) im Serum des Menschen. Antiseren wurden gegen das an Rinderserum-
albumin gebundene Bernsteins uremonoamid-Derivat des Serotonins bei Kaninchen erzeugt. Polyethylen-
glycol und anti-Kaninchen Immimglobulin wurden zur Trennung des freien und gebundenen 125I-markierten
Serotonins verwendet. Serotonin wurde durch Ethanolfallung der Serumproteine extrahiert und anschlie end
mit Essigs ureanhydrid zum N-Acetylserotonin acetyliert. Gesamtausbeute: 66%. Die Nachweisgrenze f r
N-Acetylserotonin betr gt 0,012 μπιοΐ/ΐ Serum (25 fmol pro Assayr hrchen). Der Intra-Assay-Variationskoeffi-
zient (VK> bei einer Serotoninkonzentrati n von 0,9 ± 0,06 μιηοΐ/ΐ betr gt 6,8% (n = 20), die Inter-
Assay VK bei 0,49 ± 0,049 und 2,16 + 0,53 μηιοΐ/ΐ betragen 10 bzw. 25% (n = .10). K nstlich erh hte
Serotoninkonzentrationen werden nach der Korrektur auf Extraktions- und Acetylierungsverluste zu 99 ±
13% wiedergefunden. Nur endogenes N-Acetylserotonin zeigt eine Kreuzreaktion mit dem Antik rper und
kann durch Extraktion ohne Acetylierung nachgewiesen werden.
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Die beobachteten Referenzwerte f r Serotonin im Serum betrugen: Frauen (59 Seren) 0,45 — 3,43 (χ ± s:
1,39 ± 0,63 μπιοΐ/ΐ) und M nner (59 Seren) 0,19 - 2,8 (x ± s: 1,18 + 0,56 μπιοΐ/ΐ). Alle Werte wurden um
den jeweiligen Anteil endogenen N-Acetylserotonins korrigiert: (Referenzwerte: 0 — 0,18 (χ ± s: 0,03 ±
0,03 μπιοΐ/ΐ).
Introduction
Serotonin, a well-known neurochemical transmitter,
has been strongly implicated in a number of mental
and physical disorders (1). Serotonin is located pri-
marily in the enterochromaffin cells of the intestine,
serotonergic neurons of the brain, and blood plate-
lets. Increased concentrations of circulating serotonin
have been shown in several pathological conditions
that may involve peripheral serotonergic mechanisms:
migraine (2), schizophrenia (3), carcinoid syndrome
(4), essential hypertension (5), Huntingtorfs chorea
(6), and Duchenne's muscular dystrophy (7).
Classical methods for its determination are based
on fluorescence measurements (8, 9). Recently, more
specific and sensitive methods — radioenzymic asssay
(10), mass spectrometric assay (11), liquid chro-
matography with electrochemical detection (12), and
radioimmunoassay (13 — 15) — have been described.
For a routine laboratory each of the above analytical
methods has significant drawbacks either being low
in specificity or time consuming. Although a sensitive
direct radioimmunoassay for serotonin has been re-
ported (l 5), the generally low titers of anti-serotonin
antibodies (13, 15) and the instability qf serotonin in
aqueous solution has strictly limited its applicability.
It was therefore decided to establish a ra-
dioimmunoassay for N-acetyl serotonin instead of
serotonin using a homologous [125I]-N-acyl analogue
s radioactive ligand. The specific conversion of se-
rotonin into N-acetyl serotonin by acetic anhydride
(16), the use of 125I instead of 3H (17) and the double
antibody technique allow the determination of serum
serotonin in a routine laboratory.
Buffers
Buffers used are identified by the foUowing abbreviations:
buffer A (10 mmol/1 potassium phosphale, pH 7.4, containing
1.5 mmol/1 EDTA-disodium sah (Merck, Darmstadt, F. R. G.),
3 mmol/1 sodium azide, 100 ml/l glycerol);
buffer B (10 mmol/1 potassium phosphate, pH 7.4, containing
l g/l gelatine, 3 mmol/1 sodium azide).
Isotope solulion
Appropriate amounts of HPLC-purified, iodinaled serotonin
were diluted with buffer B to a final radioactivity of 400,000
counts/min (6660 Bq) per ml.
Antiserum solution
Each antiserum was tested at different dilutions in buffer A.
The dilution which was able to bind 30% of the isotope urider
assay conditions was used.
Precipitating antiserum reagent
The precipitating antiserum (goat anti rabbit gamma globulin,
polyethyleneglycol 6000, sodium azide s preservative) was
purchased from DRG Biochemie (Marburg, F. R. G.).
Preparation of imrnunoge.n.and immunisation
The imm n gen used consisted of serotonin hemisuccinamide
bound to bovine serum albumin s described (14). The final
reaction mixture was dialysed against 0.15 mol/1 NaCl, and
insoluble reaction products were removed by filtration. Spec-
trophotometric analysis at 280 nm showed that 13 — 15 mol of
serotonin were cpupled per mol of albumin. The imm n gen
was stored at -20 °C in the dark. It is stable fof yeafs.
Rabbits were immunized with an initial dorsal injection of an
emulsion of 0.5 ml (l mg) of immunogen and 0.5 fnl of coiiiplete
Freunds adjuvant. Booster injections were given in the same
way at 4 week intervals.
Materials and Methods
Rcagen t s
Chcmicals
5-[l,2-3H(N)]Hydroxytryptamine (creatinine sulphate cofnplex,
l. l TBq/mmol) and N-succinimidyl-3-(4-hydroxy-5(3)-
[I25l]iodophenyl)propionate (n<*\-Bolion-Hunter reagent, 74
TBq/mmol) were from New England Nuclear Corp. (Dreieich,
F. R. G.). Bovine serum albumin was from Behring Institut
(Marburg, F. R. G.). 5-Hydroxytryptamine and its analogues
were ffom Sigma (M nchen, F. R. G.). Analytical grade
chemicals and glass-distilled water were used throughout.
lodination ofsero toninO 2Sl~Bolton'Hunter-serotonm con-
jugate)
Ten mg of serotonin were dissolved in l ml dry pyridine. Five
μΐ aliquots of this stock solution were mixed with appropriate
amounts (10-50 μί) of commercially available ™l-Bolton-
Hunter reagent and the reaction mixture was kept for l h at
room temperature. Solvents were removed under a gentle
stream f nitrogen in a fume cupboard, redissolved in water/
methanol (9 -l· l by Vol.) and purified by use of reversed phase
high performance liquid chromatography (PEP RPC, Phar-
macia, Uppsala). Authentic unlabeled l-Bolton-Hunter-str&
1
 tonin conjugate was prepared s described above except that
ήοη-radioactive Bolton-Hunter reagept (19) was used (tab. 2).
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Sample collection
To avoid clotted fibrin, blood samples were collected by use of
Monovette® syringes (Sarstedt, N mbrecht, F. R. G. or similar
products), and centrifuged at 1500 g. The serum was separated
and frozen at —20 °C before analysis (within two weeks). AH
samples were taken only during normal waking hours, but at
no specific time.
Serotonin extraction and sample preparation
Sera were diluted with double-distilled water (l + 4). One
hundred μΐ of diluted serum and 2 ml of ethanol were added
to a glass tube and carefully vortexed. The mixture was kept
for 30 min at 4 °C to complete the precipitation of proteins
and centrifuged at 2000 g. The clear supernatant was decanted
into a glass tube and 50 μΐ of a pyridine/acetic anhydride (l +
l; by vol.) solution was added. The tube was carefully vortexed,
placed in a heated water bath (50 °C), and the organic solvent
removed by evaporation under a gentle stream of nitrogen.
One ml of buffer A was added and the tube heated (70 °C) for
30 min, then vortexed for no less than 30 seconds. The extracts
were stored a t 0—4 °C (no longer than l week).
Radioimmunoassay procedure
One hundred μΐ of serum extract, 100 μΐ of isotope solution,
and 100 μΐ of diluted antiserum were added to a polystyrene
tube and incubated overnight at 4 °C (1h at 37 °C, respec-
tively). One ml of precipitating antibody was added, the mixture
incubated for a further 10 min at room temperature and cen-
trifuged (1500#, 15 min, 4 °C). The tube was decanted and the
pelleted radioactivity determined in a gamma-counter.
Each series consisted of a Standard curve (0.12—9.26 pmol
serotonin), unspecific binding, quality control samples and the
samples to be assayed.
There was no significant loss of serotonin content of
20 different samples when stored for two weeks at
-20°C.
Extraction and acetylation of serotonin
Twenty different sera (including haemolytic and
lipaemic samples) were enriched with 33.3 kBq of
[3H]serotonin per ml. After five-fold dilution with
water and precipitation of proteins with ethanol, 100
μΐ aliquots of the ethanolic extracts were withdrawn
and counted for radioactivity. The analytical recovery
of [3H]serotonin from all sera was 71% (SD 2%)
(tab. 1). In a second set of experiments the ethanolic
extracts were acetylated with acetic anhydride and
l ml aliquots were withdrawn for thin-layer chro-
matography (tab.l). No side reactions of [3H]sero-
tonin with acetic anhydride were observed by either
thin-layer chromatography (data not shown) or re-
versed phase high performance liquid chro-
matography (fig. 2). The analytical recovery of [3H]N-
acetyl serotonin was 93% (SD 3%) (tab. 1).
The remaining l ml of acetylated extracts was dried
by evaporation under a gentle stream of nitrogen.
The residue was carefully redissolved in 500 μΐ of
buffer A and 100 μΐ aliquots withdrawn for both
radioactivity measurements and radioimmunosassay.
The generally observed turbidity of the buffered ex-
tracts did not interfere with the subsequent ra-
dioimmunoassay procedure.
Results
Immunisa t ion
Ten rabbits were imrnunised. During the process of
immunisation the binding capacities and the
equilibrium constants for the antisefa were estimated
according to Scatchard (19, 20). Concentrations of
free and proteiri bo nd ligand were determinated by
the dextran-coated charcoal techriique (20). Useable
antisera were obtained from two rabbits aftef, six
months of immunisation. The antiserum with the
highest equilibrium constant (Kd = 3 · 10~H mol/1)
was diluted l : 1000 with buffer A (final assay dilution
l : 3000) and used in the experiments described in
this paper.
Condit ions for storage of serurn
Many previ us reports have commented on the ap-
propriate storage for serotonin blood samples. The
long-term stab'ility of frozen serum serotonin was
examined by determination of the inter-assay coeffi-
cient of Variation of our radioimmunoassay System.
Tab. l. Analytical recoveries of extraction and acetylation of
[3H]serotonin in twenty different sera.
Step
Ethanol extraction
Acetylation6
Buffer solution
Recovery (%)a
Mean
71
93
93
SD
2
3
4
a
 The overall recovery of N-acetylated [3H]serotonin is the
product of mean recoveries of extraction and acetylation and
was approximately 66%. The final value for serotonin is
obtained by multiplying the radioimmunoassay results by 1.5,
which corrects for the average 66% recovery.
b
 The recovery of acetylated [3H]serotonin was determined s
follows: One ml of acetylated ethanolic extract (1.6 kBq)
was enriched with l mg of serotonin and l mg of N-acetyl
serotonin respectively. The solvent was removed under ni-
trogen and the residue redissolved in 50 μΐ of ethyl acetate.
Preparative thin-layer chromatography was performed on
Merck F-254 precoated silica gel plates in solvent Systems
ethanol/ethylacetate/NH3 (5-1-5+1, by vol.) and n-butanol/
acetic acid/H2O (124-3+4, by vol.). Serotonin and N-acetyl
serotonin spots were scraped ofT and counted for radio-
activity.
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Because of the analytical recoveries of both extraction
(71 ± 2%) and acetylation (93 + 3%) a constant
factor of 1.5 was introduced to correct the serotonin
values of unknown sera for losses during sample
preparation (tab. 1).
Endogenous N-acetyl serotonin
The N-acetyl serotonin content of all sera was deter-
mined by the same extraction procedure except that
the acetylation step was omitted. The levels were 0.03
+ 0.03 μτηοΐ/ΐ (0-0.18 μπιοί observed r nge). All
values in this study are corrected for endogenous N-
acetyl serotonin.
Standard curve
A typical Standard curve is shown in figure 1. The
Standard curve is sigmoid over the r nge of
0.12-9.26 pmol/tube. As the sample preparation in-
cludes a 50-fold dilution of sera, the Standard curve
actually covers the r nge of 0.06—4.63 μιηοΐ/ΐ serum.
1.00
0.90
0.80
0.70
Hof °·60
0.70
0.40
0.30
0.20
0.10
0.054 0.53
Serotonin Cftmol/U
5.23
Fig. 1. Typical Standard curve for the radioimmunoassay of N-
acelylated serotonin.
The abscissa represents the concentrations of N-acetyl
serotonin in the Standards corrected for the fifty-fold
dilution of serum during sample preparation.
The sensitivity of the assay is enhanced 20-fold if 100
μΐ of normal sera instead of l : 5 diluted sera are
extracted and the acetylated extracts are redissolved
in 250 μΐ instead of l ml of buffer A. This "enhanced
sensitivity extraction" procedure uses the same Stan-
dard, isotope, and antibody Solutions except that the
Standard curve n w covers the r nge of 3—231 nmol/1
(0.6 nmol/1 serum minimal detectable concentration).
Specificity
The specificity of antibody for N-acetyl serotonin is
demonstrated in figure 2. Reversed phase high pres-
sure liquid chromatography of [3H]serotonin-en-
riched acetylated human serum extracts reveals only
one peak detectable by radioimm noassay, which
also contains more than 90% of total radioactivity.
The retention time of this peak is identical with that
of authentic N-acetyl serotonin.
0.62 -i 5000 -i 0.5
 Ί
o
0.36 -
z 0.12 -
~ 3000 -
1000 -
10.3-
0.1 -
1.00
- 0.80
r 0.60 ~ .s
21
lll· 0.40 11
- 0.20
Fig. 2. High performance liquid chromatography of a human
serum extract enriched with [3H]serotonin. Localization
of N-acetyl serotonin by RIA.
One ml of human serum was enriched with 33.3 kBq
of [3H]serotonin per ml, and serotonin was extracted
and acetylated s described in Materials and Metfoods.
In contrast to the RIA proeedure, the acetylated extract
was redissolved in water/methanol (9 + l, by vol.) and
submitted to isocratic reversed phase high performance
liquid chromatography on a PEP RPC column (Phar-
macia, Freiburg, F. R. G.). Fractions of l ml were col-
lected for the determination of radioactivity and N-
acetyl serotonin (by RIA).
Minimum detectable concentration
The within-day CV of the zero-dose Standard is
< 2%. Therefore, the minimal detectable con-
centration is the concentration at which B/B0 is ap-
proximately 0.96 (1-2 CV), or 0.012 μπκ>1/1 serum
(25 fmol/tube).
The Inhibition, by structurally related compounds, of
the binding of nsI-Bolton-Hunter-serotonin con-
jugates by antibody is shown in«table2. The data
show that the acylation of the free amino group of
serotonin is a prerequisite for the specific recognition
of the 5-hydroxindole nucleus by antibody (due to
the "bridge" effect of the imMunogen recognition!).
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Tab. 2. Inhibition by serotonin analogues of binding of
 The inter-assay CV for 10 consecutive assays at a[I25l]serotonin by antibody. , , „
 Λ Λ^ Α Λ
 J
— 1 1 level of 0.49 ± 0.049 μιηοΐ/l was 10%, and 25% at
r* A r^
 a ievej Of 2.16 ± 0.53).Compound Cross-
reactivity (%)a
l-Bolion A/ww/er-serotonin conjugateb
N-Acetyl serotonin
N-Propionyl serotonin
Serotonin
Melatonin
5-Methoxytryptamine
5-Hydroxy-3-indolylacetic acid
Trpytamine
N-Acetyltryptamine
Tryptophan
Tyrosine
5-Hydroxytryptophan
5-Methoxytryptophan
L-Dopa
Dopamine
N-Acetyl dopamine
100
98
34
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
<0.01
a
 The potency of serotonin analogues to inhibit 50% of the}2S\-Bolfon //z/mer-serotonin conjugatc binding by antibody.
The non-radioactivc l- olton Hunier-SQTOlonin conjugate is
set at 100% and the cross reaction of serotonin analogues is
by weight. The radioimmunoassay was performed s de-
scribed under "Material and Methods".
h
 N-(3-(4-hydroxy-3(5)-iodophenyl)-propionyl) serotonin.
Recovery
Thirty different sefa (including haemolytic and
lipaemic probes) were tested. Aliquots were enriched
with 0.62 μηιοΐ/ΐ serotonin, and both normal and en-
riched sera were prepared for radioimmunoassay. The
values thus obtained were corrected for losses during
sample preparation (factor 1.5) and the differences
between enriched and normal sera determined. Ana-
lytical recovery was 99% (SD 13%).
Precision
Sera were stored in aliq ots at —20 °C and used to
estimate the intra- and inter-assay precisiori. The
intra-assay CV at the levels of 0.9 ± 0.06 μπιοΐ/ΐ
and 1.7 ± 0.18 μπιοΙ/1 was 6.8% and 11% for 20
consecutive determinations respectively.
Tab. 3. Reference intervals fpr serotonin in serum of healthy
donors.
Number
Age (years)
Serotonin concentration
Mean
SD
Observed r nge
Men
59
18-60
(μιηοΐ/ΐ)
1.18
±0.56
0.19-2.8
Women
59
19-55
1.37
±0.63
0.45-3.43
Reference intervals
The observed r nge for the concentration of sero-
tonin in serum of healthy male and female probands
is shown in table 3. All values are corrected for en-
dogenous N-acetyl serotonin.
Discussion
We have determined serotonin by radioimmunoassay,
because this method is faster, more sensitive and more
specific than previously described methods (9 — 15).
The determination of N-acetylated serotonin has sev-
eral additional advantages: firstly, antigen, isotope
and N-acetylserotonin, are N-acyl homologues of
serotonin; secondly, there is no cross-reactivity of
the antibody with endogenous serotonin; thirdly, the
need of acetylation prior to radioimmunosassay
strictly limits the number of possibly cross-reacting
compounds to amines. Endogenous N-acetyl sero-
tonin, a metabolite of serotonin (21), which could
falsify the assay is detectable by direct comparison
of acetylated and nonacetylated extracts.
The major "compartment" for serotonin in the blood
is in the platelets, from which it is released during
blood coagulation (22). It has previously been shown
that the concentration of serotonin in plasma is only
on the average 2% of that in serum. The addition of
monoamine oxidase inhibitors (23) and an inhibitor
of the platelet uptake of serotonin (24) to the blood
specimen just after sampling increased the yield of
serotonin only by about 10%, whereas inducers of
the platelet release reaction had no detectable effect
on the serum concentrations of serotonin (15).
The concentration of serotonin in serum is a measure
of the serotonin content of the platelets, provided
that appropriate precautions are taken. We find that
blood coagulation in the presence of fibrin-adsorbing
surfaces (serum Monovette) is a prerequisite to a
constant recovery of platelet serotonin, because clot-
ted fibrin may cause erroneous results (data not
shown). Blood samples should not be stored at el-
evated temperatures and no longer than two hours.
Fluorometrically, the serotonin content of platelets
has been found to be about 700 ng/109 platelets (15,
25, 26). These results lead one to expect a. con-
centration of serotonin in serum of about 1.5 μιηοΐ/ΐ.
We obtain a quite similar value for women, whereas
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the value for men is about 15 percent lower. A similar
sex-related difference has also been observed by other
authors (15, 27). Only one third (15) or one-half
(26) of this concentration was found by previously
described methods. However, in both these cases,
clotted fibrin might have caused the low results.
The present investigation shows that the ra-
dioimmunoassay of N-acetylated serotonin is highly
sensitive for the analysis of serotonin in a variety of
blood samples. The acceptable coefficients of Vari-
ation exhibited by the method should facilitate the
examination and comparison of groups that differ
only slightly from one another with respect to se-
rotonin levels.
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